A phase Ib study of AZD5462 on top of dapagliflozin in participants with heart failure and moderate renal impairment

Trial Identifier:	D9090C00007
Sponsor:	AstraZeneca
Collaborator:	Parexel
Start Date:	September 2024
Primary Completion Date:	May 2025
Study Completion Date:	May 2025
Condition:	Congestive Heart Failure; Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	Bulgarian Translation
	English Version
	Swedish Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
BG	Sofia, BG, 1612

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.